Dominick Angiolillo

Showing 1-7 of 7 articles

De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus

Capranzano P, Angiolillo D

August 9, 2019 | 10.4244/EIJV15I6A89

Coronary interventions

Crushed ticagrelor in comatose patients treated with primary percutaneous coronary intervention

Rollini F, Franchi F, Angiolillo D

February 20, 2017 | 10.4244/EIJV12I14A276

Coronary interventions

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

De Servi S, Crimi G, Calabrò P, Piscione F, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Angiolillo D, Palmerini T

June 20, 2016 | 10.4244/EIJV12I3A51

Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies

Rossini R, Musumeci G, Visconti L, Bramucci E, Castiglioni B, De Servi S, Lettieri C, Lettino M, Piccaluga E, Savonitto S, Trabattoni D, Capodanno D, Buffoli F, Parolari A, Dionigi G, Boni L, Biglioli F, Valdatta L, Droghetti A, Bozzani A, Setacci C, Ravelli P, Crescini C, Staurenghi G, Pietro Scarone P, Francetti L, D’Angelo F, Gadda F, Comel A, Salvi L, Lorini L, Antonelli M, Bovenzi F, Cremonesi A, Angiolillo D, Guagliumi G

May 20, 2014 | 10.4244/EIJV10I1A8

Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial

Jimenez-Quevedo P, Hernando L, Gomez-Hospital J, Iñiguez A, SanRoman A, Alfonso F, Hernández-Antolín R, Angiolillo D, Banuelos C, Escaned J, Gonzalo N, Fernandez C, Macaya C, Sabate M

July 26, 2013 | 10.4244/EIJV9I3A54

Diabetes mellitus: the scary killer haunting silently

Capodanno D, Angiolillo D

April 12, 2010

Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome

Gomez-Moreno S, Sabate M, Jimenez-Quevedo P, Vazquez P, Alfonso F, Angiolillo D, Hernández-Antolín R, Moreno R, Banuelos C, Escaned J, Macaya C

August 20, 2006

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Coronary Artery Thrombosis in COVID-19

Coronary collaterals, the natural grafts of CTO lesions

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

(The Trials book is supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease